US FDA Inspectors See Cloudy GMP Compliance At OTC Ophthalmic Drug Manufacturers

Agency warns two drug firms providing OTC eye drops about failing to maintain sanitary conditions after early in 2023 announcing Indian firm Global Pharma Healthcare made artificial tear products recalled due to potential infection from bacterial contamination not previously seen in US.